ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2.

Beata Holkova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.